48. CLINICAL AND PARACLINCAL CHARACTERISTICS OF CHILDREN OVER 5 YEARS OLD WITH PNEUMONIA AND PCR POSITIVE FOR MYCOPLASMA PNEUMONIAE

Nguyen Thanh Nam1, Do Hoang Hai1, Nguyen Ngoc Thai2, Pham Trung Kien3, Pham Van Dem1,3
1 Bach Mai Hospital
2 Phu Tho Viet Duc General Hospital
3 VNU, University of Medicine and Pharmacy

Main Article Content

Abstract

Objective: To describe the clinical and paraclinical characteristics of children over 5 years old diagnosed with pneumonia and positive for Mycoplasma pneumoniae by PCR at the Pediatric Center, Bach Mai Hospital.


Subjects and methods: A descriptive study was conducted on 50 children diagnosed with pneumonia and confirmed positive for M. pneumoniae by PCR in nasopharyngeal samples, treated at the Pediatric Center, Bach Mai Hospital, from January 1, 2023 to December 31, 2023.


Results: The highest proportion (84%) in the 6-11 years age group. The most common symptoms were cough (98%), fever (92%), tachypnea (58%). Among these, productive cough and fever were the most prevalent symptoms in the M. pneumoniae-positive pneumonia group, occurring in over 95% of cases. The most frequent physical examination findings included moist rans in the lungs (68%) and tachypnea (58%); less common findings were decreased breath sounds (32%), bronchial rans (6%), and chest retractions (2%). The lesions on X-ray were mainly localized lesions accounting for 62%. The severity of pneumonia with the pneumonia/severe pneumonia ratio was 7.3/1. Some factors related to pneumonia with PCR positive for M. pneumoniae were the average time from symptom onset to hospital admission, and the duration of fever in the group of pneumonia due to M. pneumoniae was longer than that of the group of pneumonia negative for M. pneumoniae.


Conclusions: PCR-confirmed M. pneumoniae pneumonia was most commonly found in children aged 6-11 years. The predominant symptoms were cough, fever, moist rans in the lungs, and tachypnea. Chest X-ray findings primarily showed localized lung lesions.

Article Details

References

[1] World Health Organization, Pneumonia, who.int, 2022.
[2] Waites K.B, Xiao L, Liu Y et al, Mycoplasma pneumoniae from the Respiratory Tract and Beyond, Clinical Microbiology Reviews, 2017, 30 (3), 747-809.
[3] Bộ Y tế, Viêm phổi không điển hình - Hướng dẫn chẩn đoán và điều trị một số bệnh thường gặp ở trẻ em, 2015.
[4] Medjo B, Atanaskovic-Markovic M, Radic S et al, Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis, Italian Journal of Pediatrics, 2014, 40 (1).
[5] Bộ Y tế, Hướng dẫn chẩn đoán và điều trị một số bệnh thường gặp ở trẻ em, 2015.
[6] Phạm Thu Hiền, Đặc điểm lâm sàng viêm phổi không điển hình do vi khuẩn ở trẻ em tại Bệnh viện Nhi Trung ương năm 2014, Tạp chí Y dược Lâm sàng 108, 2018, 13 (1), 33-39.
[7] Đặng Mai Liên, Lê Thị Hồng Hanh, Hoàng Thị Thu Hằng và cộng sự, Đặc điểm lâm sàng, cận lâm sàng ở bệnh nhi mắc viêm phổi nặng do Mycoplasma pneumonia và mô tả một số yếu tố liên quan đến tình trạng viêm phổi nặng do Mycoplasma pneumonia ở bệnh nhi tại Bệnh viện Nhi Trung ương, Tạp chí Nhi khoa, 2023, 16 (5), 1-8.
[8] Kutty P.K, Jain S, Taylor T.H et al, Mycoplasma pneumoniae among Children Hospitalized With Community-acquired pneumonia, clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 2019, 68 (1), 5-12.
[9] Biljana Medjo, Soh J.E, Kwak J.H et al, Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia, Korean J Pediatr, 2018, 61 (8), 258-263.